Worldwide Pharma Chem Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 31-07-2024
- Paid Up Capital ₹ 0.40 M
as on 31-07-2024
- Company Age 18 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.80 M
as on 31-07-2024
- Satisfied Charges ₹ 2.00 M
as on 31-07-2024
- Revenue -16.78%
(FY 2023)
- Profit -7.52%
(FY 2023)
- Ebitda 21.57%
(FY 2023)
- Net Worth 53.61%
(FY 2023)
- Total Assets 49.58%
(FY 2023)
About Worldwide Pharma Chem
The Corporate was formerly known as Godavarei Finechem Private Limited. The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 0.40 M.
The company currently has active open charges totaling ₹3.80 M. The company has closed loans amounting to ₹2.00 M, as per Ministry of Corporate Affairs (MCA) records.
Kalapala Srihari and Kalapala Savithri serve as directors at the Company.
- CIN/LLPIN
U24110TG2006PTC051366
- Company No.
051366
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Oct 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Worldwide Pharma Chem?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kalapala Srihari  | Director | 13-Dec-2022 | Current |
| Kalapala Savithri | Additional Director | 09-Oct-2006 | Current |
Financial Performance of Worldwide Pharma Chem.
Worldwide Pharma Chem Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 16.78% decrease. The company also saw a slight decrease in profitability, with a 7.52% decrease in profit. The company's net worth Soared by an impressive increase of 53.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Worldwide Pharma Chem?
In 2023, Worldwide Pharma Chem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Efficient Agrichem Private LimitedActive 10 years 2 monthsKalapala Srihari and Kalapala Savithri are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 26 Apr 2024 | ₹2.80 M | Open |
Others Creation Date: 01 Jul 2020 | ₹1.00 M | Open |
The Karur Vysya Bank Limited Creation Date: 02 Jun 2008 | ₹2.00 M | Satisfied |
How Many Employees Work at Worldwide Pharma Chem?
Unlock and access historical data on people associated with Worldwide Pharma Chem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Worldwide Pharma Chem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Worldwide Pharma Chem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
